QView Medical news
QView Medical is pleased to announce FDA approval for QVCAD to be used with the GE Invenia™ ABUS in breast screening for asymptomatic dense breasted women whose mammogram was negative.
QVCAD is the next generation CAD system for automated breast ultrasound ("ABUS") based on deep learning algorithms. The QVCAD innovative C-Thru technology combined with ABUS has demonstrated a 33% improved reading time while preserving diagnostic accuracy. The innovative QVCAD case review pr
QView Medical, a breast cancer detection pioneer and maker of the FDA-approved artificial intelligence (AI) software system for breast cancer screening, and GE Healthcare today announced that QView`s QVCAD software can be launched on GE Healthcare`s Invenia™ ABUS 2.0 (Automated Breast Ultrasound), which has an open platform technology that allows the integration of third-party AI tools for the optimization of the reading workflow.
Invenia ABUS 2.0 is the first
QView Medical is the only FDA AI Ultrasound Technology approved for breast screening. But now, we are moving beyond the clinical suite. QView is joining women in the initiative around Breast Cancer with the launch of AmIDense.com and the supporting #AmIDense. Let`s START the conversation around Breast Density.
The 2021 American Cancer Society`s estimate is 280,000 women wi
QView Medical and Traf Intercontinental announce a distribution agreement under which Traf International will sell QView Medical`s QVCAD System to breast imaging clinics in Europe. QVCAD is the AI solution to assist the radiologist in detecting breast cancer in 3D Automated Breast Ultrasound images
In this post-CoVid-19 environment, QView Medical searched for a more direct sales focus in Europe. Traf was chosen for its extensive experience a
QView Medical will showcase QVCAD, the first AI CAD system FDA-Approved for concurrent reading of Automated Breast Ultrasound (ABUS) exams, at the upcoming 104th Annual Radiological Society of North America (RSNA) meeting, November 25-30, 2018 (South Hall #3572). Being demonstrated for the first time since being approved, QVCAD reduces interpretation time of screening ABUS exams while maintaining diagnostic accuracy.
In addition, QView successfully completed an installatio